Press Releases

Press Releases

February 14, 2019
CytomX Therapeutics to Announce Full-Year 2018 Financial Results
-Teleconference Scheduled for February 27, 2019 , at 5:00 p.m. ET - -Company to Host Research and Development Day on February 26, 2019 in New York City - SOUTH SAN FRANCISCO, Calif. , Feb. 14, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused
Additional Formats
February 5, 2019
CytomX Therapeutics Announces Senior Management Appointments
Leadership Team Further Strengthened with Additions of Nick Galli, J.D., as SVP, Chief Business Officer and Leslie Robbins, J.D. as SVP, Intellectual Property SOUTH SAN FRANCISCO, Calif. , Feb. 05, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused
Additional Formats